Autres langues Monte Rosa Therapeutics, Inc.

Actions

GLUE

US61225M1027

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 21/08/2026			Varia. 5j.	Varia. 1 janv.
14,30 ^USD	-3,25 %		-7,74 %	-8,80 %

06/08	Monte Rosa Therapeutics, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
06/08	Flash résultats (GLUE) : Monte Rosa Therapeutics, Inc. publie un chiffre d'affaires de collaboration de 9,0 millions de dollars au deuxième trimestre, contre une estimation FactSet de 12,9 millions de dollars	MT

Autres langues

06/08	Monte Rosa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
06/08	Earnings Flash (GLUE) Monte Rosa Therapeutics, Inc. Reports Q2 Collaboration Revenue $9.0M, vs. FactSet Est of $12.9M
06/08	Monte Rosa Therapeutics: Q2 Earnings Snapshot
06/08	Monte Rosa Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
31/07	Novo Nordisk Shares Sink After Heart Disease Drug Candidate Fails Late-Stage Trial
02/07	Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29/06	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 2500 Growth Benchmark
29/06	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell Microcap Value Benchmark Index
29/06	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell 2000 Value Benchmark
29/06	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell Microcap Growth Benchmark Index
29/06	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 2000 Growth Benchmark
29/06	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 3000E Growth Benchmark
29/06	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell 3000E Value Benchmark
29/06	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell 3000 Value Benchmark
29/06	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 3000 Growth Benchmark
29/06	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell Small Cap Comp Value Benchmark
29/06	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell Small Cap Comp Growth Benchmark
29/06	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell 2500 Value Benchmark
02/06	Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/05	Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
07/05	Monte Rosa Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
07/05	Monte Rosa Therapeutics: Q1 Earnings Snapshot
07/05	Earnings Flash (GLUE) Monte Rosa Therapeutics, Inc. Reports Q1 Revenue $4.2M, vs. FactSet Est of $11.4M
07/05	Monte Rosa Therapeutics : Corporate Presentation – May 2026
07/05	Monte Rosa Therapeutics Announces First Quarter 2026 Financial Results and Business Updates